$VGAS
Verde Clean Fuels Inc Stock $vgas

$vgas Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024097136 Filed on November 13, 2024

Income Statement

Concept	2024 Q3	2023 Q4
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$2.280M
YoY Change
% of Gross Profit
Research & Development	$91.30K	$82.41K
YoY Change	16.59%
% of Gross Profit
Depreciation & Amortization		$1.730K
YoY Change
% of Gross Profit
Operating Expenses	$91.30K	$2.363M
YoY Change	16.59%	80.37%
Operating Profit	-$2.785M
YoY Change	7.54%
Interest Expense		$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$291.4K	$208.2K
YoY Change	102.35%
Pretax Income	-$2.493M	-$2.155M
YoY Change	-0.78%	-1367.48%
Income Tax		$47.08K
% Of Pretax Income
Net Earnings	-$777.7K	-$646.8K
YoY Change	-70.45%	397.53%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.11
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$28.78M
YoY Change		-83.82%
Cash & Equivalents	$21.67M	$28.78M
Short-Term Investments
Other Short-Term Assets		$473.3K
YoY Change
Inventory
Prepaid Expenses		$373.3K
Receivables
Other Receivables
Total Short-Term Assets	$22.77M	$29.25M
YoY Change	-29.04%	21627.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$749.0K	$62.51K
YoY Change	8844.45%	743.07%
Goodwill
YoY Change
Intangibles	$1.925M	$1.925M
YoY Change	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets	$162.1K	$160.7K
YoY Change	-39.66%	-91.65%
Total Long-Term Assets	$3.134M	$2.673M
YoY Change	26.56%	-98.5%
TOTAL ASSETS
Total Short-Term Assets	$22.77M	$29.25M
Total Long-Term Assets	$3.134M	$2.673M
Total Assets	$25.91M	$31.93M
YoY Change	-25.06%	-82.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.071M	$184.3K
YoY Change	125.34%	-93.55%
Accrued Expenses	$2.211M	$1.977M
YoY Change	-1.75%	159.38%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.521M	$2.459M
YoY Change	-7.88%	-66.86%
LONG-TERM LIABILITIES
Long-Term Debt		$409.6K
YoY Change
Other Long-Term Liabilities		$232.2K
YoY Change		-94.6%
Total Long-Term Liabilities	$93.90K	$641.8K
YoY Change		-53.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.521M	$2.459M
Total Long-Term Liabilities	$93.90K	$641.8K
Total Liabilities	$3.615M	$3.100M
YoY Change	-5.42%	-73.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.38M	-$23.92M
YoY Change	13.32%	120.02%
Common Stock	$36.45M	$35.01M
YoY Change		9514801.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$11.10M
YoY Change
Total Liabilities & Shareholders Equity	$25.91M	$31.93M
YoY Change	-25.06%	-82.11%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$777.7K	-$646.8K
YoY Change	-70.45%	397.53%
Depreciation, Depletion And Amortization		$1.730K
YoY Change
Cash From Operating Activities		-$2.319M
YoY Change		791.88%
INVESTING ACTIVITIES
Capital Expenditures		$55.87K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$55.87K
YoY Change		-96.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities		-2.319M
Cash From Investing Activities		-55.87K
Cash From Financing Activities		0.000
Net Change In Cash		-2.375M
YoY Change		-2078.98%
FREE CASH FLOW
Cash From Operating Activities		-$2.319M
Capital Expenditures		$55.87K
Free Cash Flow		-$2.375M
YoY Change		813.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40743
CY2024Q3	us-gaap	Liabilities Liabilities	3614994	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3100309	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36451797	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35014836	usd
	dei	Entity Registrant Name EntityRegistrantName	Verde Clean Fuels, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1863331
	dei	Entity Address Address Line1 EntityAddressAddressLine1	711 Louisiana St
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2160
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	City Area Code CityAreaCode	(908)
	dei	Local Phone Number LocalPhoneNumber	281-6000
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21673151	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28779177	usd
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	242138	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	759285	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	373324	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	22774574	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	29252501	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	749008	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62505	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	297335	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	524813	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	162119	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	160669	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	3133613	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2673138	usd
CY2024Q3	us-gaap	Assets Assets	25908187	usd
CY2023Q4	us-gaap	Assets Assets	31925639	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1070636	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	184343	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2211319	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1976812	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	221213	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	297380	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17928	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3521096	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2458535	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93898	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	232162	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	93898	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	641774	usd
CY2024Q3	us-gaap	Liabilities Liabilities	3614994	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3100309	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36451797	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35014836	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26376540	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23922730	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	12214731	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	17730035	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	641774	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3100309	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36451797	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35014836	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26376540	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23922730	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	12214731	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25908187	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31925639	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2693490	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2511176	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8471640	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9234697	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	91303	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78314	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	246788	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2784793	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8182485	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	291385	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	144004	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	953721	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	238891	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	67430	usd
	us-gaap	Interest Expense InterestExpense	236699	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2493408	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2512916	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7868077	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8180293	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119186	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13866	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119186	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2493408	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2632102	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1715676	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1858910	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5400401	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6202678	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-777732	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-773192	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2453810	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24385467	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	401134	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2493408	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33104716	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	276880	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2632102	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30749494	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23922730	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	12214731	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25908187	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31925639	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2693490	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2511176	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8471640	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	91303	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	350158	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	246788	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2784793	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2589490	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8182485	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	291385	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	144004	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	238891	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	67430	usd
	us-gaap	Interest Expense InterestExpense	236699	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2493408	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2512916	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7868077	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8180293	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13866	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119186	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2493408	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2632102	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1715676	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1858910	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5400401	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6202678	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-773192	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2453810	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2096801	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24385467	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	401134	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2493408	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33104716	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	276880	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2632102	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30749494	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	409612	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	912462	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
	vgasw	Stock Issued During Period Value Reversal Of Intermediate Original Equity StockIssuedDuringPeriodValueReversalOfIntermediateOriginalEquity	-1103365	usd
	vgasw	Stockissue During Period Value Recapitalization Transaction StockissueDuringPeriodValueRecapitalizationTransaction	36089053	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2623936	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25908187	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31925639	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2693490	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2511176	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8471640	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9234697	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	91303	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78314	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	350158	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	246788	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2784793	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2589490	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8821798	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	291385	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	144004	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	953721	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	67430	usd
	us-gaap	Interest Expense InterestExpense	236699	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2493408	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7868077	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8180293	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119186	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13866	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119186	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2493408	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2632102	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1715676	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1858910	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5400401	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6202678	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-777732	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-773192	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2453810	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24385467	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	401134	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2493408	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33104716	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	276880	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2632102	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30749494	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	409612	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	912462	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
	vgasw	Stock Issued During Period Value Reversal Of Intermediate Original Equity StockIssuedDuringPeriodValueReversalOfIntermediateOriginalEquity	-1103365	usd
	vgasw	Stockissue During Period Value Recapitalization Transaction StockissueDuringPeriodValueRecapitalizationTransaction	36089053	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2623936	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	912462	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22293193	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
	vgasw	Stock Issued During Period Value Reversal Of Intermediate Original Equity StockIssuedDuringPeriodValueReversalOfIntermediateOriginalEquity	-1103365	usd
	vgasw	Stockissue During Period Value Recapitalization Transaction StockissueDuringPeriodValueRecapitalizationTransaction	36089053	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2623936	usd
	vgasw	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	335984	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30749494	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
	us-gaap	Depreciation Depreciation	9687	usd
	us-gaap	Depreciation Depreciation	1763	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	912462	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2623936	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	127617	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	227478	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	216743	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	387410	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	699253	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	707314	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	284132	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-55758	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	351453	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-214431	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-210530	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	393	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-108850	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6655262	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6793768	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1445174	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2723	usd
	vgasw	Reimbursement Of Capital Expenditures ReimbursementOfCapitalExpenditures	994410	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-450764	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2723	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32000000	usd
	vgasw	Proceeds From Trust ProceedsFromTrust	19031516	usd
	vgasw	Paymentsof Transaction Expenses PaymentsofTransactionExpenses	10043793	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3750000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-11166	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	44469	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	335984	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	22570	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37495502	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7106026	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	30699011	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28879177	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463475	usd
CY2023Q3	vgasw	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired	91454	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21773151	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31253940	usd
	vgasw	Noncash Income Tax Payable And Deferred Tax Liability Obtained From Cenaq NoncashIncomeTaxPayableAndDeferredTaxLiabilityObtainedFromCENAQ	312446	usd
	vgasw	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination	409612	usd
	vgasw	Accounts Receivable For Reimbursement Of Capital Expenditures AccountsReceivableForReimbursementOfCapitalExpenditures	223818	usd
	vgasw	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	335984	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30749494	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
	us-gaap	Depreciation Depreciation	9687	usd
	us-gaap	Depreciation Depreciation	1763	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	912462	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2623936	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	127617	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	227478	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	216743	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	387410	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	707314	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-55758	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	351453	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-214431	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	393	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-108850	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6655262	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1445174	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2723	usd
	vgasw	Reimbursement Of Capital Expenditures ReimbursementOfCapitalExpenditures	994410	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-450764	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2723	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32000000	usd
	vgasw	Proceeds From Trust ProceedsFromTrust	19031516	usd
	vgasw	Paymentsof Transaction Expenses PaymentsofTransactionExpenses	10043793	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3750000	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	44469	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	335984	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	22570	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37495502	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7106026	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	30699011	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28879177	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463475	usd
CY2023Q3	vgasw	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired	91454	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21773151	usd
	vgasw	Noncash Income Tax Payable And Deferred Tax Liability Obtained From Cenaq NoncashIncomeTaxPayableAndDeferredTaxLiabilityObtainedFromCENAQ	312446	usd
	vgasw	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination	409612	usd
	vgasw	Capital Expenditures In Accounts Payable And Accrued Expensesat Period End CapitalExpendituresInAccountsPayableAndAccruedExpensesatPeriodEnd	469244	usd
	vgasw	Accounts Receivable For Reimbursement Of Capital Expenditures AccountsReceivableForReimbursementOfCapitalExpenditures	223818	usd
	vgasw	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	335984	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30749494	usd
	us-gaap	Profit Loss ProfitLoss	-7854211	usd
	us-gaap	Profit Loss ProfitLoss	-8299479	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
	us-gaap	Depreciation Depreciation	9687	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2623936	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	127617	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	227478	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	387410	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	699253	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	707314	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	284132	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-55758	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	351453	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-214431	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-210530	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	393	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-108850	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6655262	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1445174	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2723	usd
	vgasw	Reimbursement Of Capital Expenditures ReimbursementOfCapitalExpenditures	994410	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2723	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32000000	usd
	vgasw	Proceeds From Trust ProceedsFromTrust	19031516	usd
	vgasw	Paymentsof Transaction Expenses PaymentsofTransactionExpenses	10043793	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3750000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37495502	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7106026	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28879177	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463475	usd
CY2023Q3	vgasw	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired	91454	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21773151	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31253940	usd
	vgasw	Noncash Income Tax Payable And Deferred Tax Liability Obtained From Cenaq NoncashIncomeTaxPayableAndDeferredTaxLiabilityObtainedFromCENAQ	312446	usd
	vgasw	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination	409612	usd
	vgasw	Capital Expenditures In Accounts Payable And Accrued Expensesat Period End CapitalExpendituresInAccountsPayableAndAccruedExpensesatPeriodEnd	469244	usd
	vgasw	Accounts Receivable For Reimbursement Of Capital Expenditures AccountsReceivableForReimbursementOfCapitalExpenditures	223818	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The most significant estimates pertain to the calculations of the fair values of equity instruments, impairment of intangible and long-lived assets and income taxes. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	19942258	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	26155789	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Corporation (“FDIC”) limit of $250,000. Additionally, the majority of the Company’s cash balances are held in a short-term money market fund that is not guaranteed by the FDIC. As of September 30, 2024 and December 31, 2023, the Company had not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The most significant estimates pertain to the calculations of the fair values of equity instruments, impairment of intangible and long-lived assets and income taxes. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	19942258	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	26155789	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Corporation (“FDIC”) limit of $250,000. Additionally, the majority of the Company’s cash balances are held in a short-term money market fund that is not guaranteed by the FDIC. As of September 30, 2024 and December 31, 2023, the Company had not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The most significant estimates pertain to the calculations of the fair values of equity instruments, impairment of intangible and long-lived assets and income taxes. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	19942258	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	26155789	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Corporation (“FDIC”) limit of $250,000. Additionally, the majority of the Company’s cash balances are held in a short-term money market fund that is not guaranteed by the FDIC. As of September 30, 2024 and December 31, 2023, the Company had not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	215104	usd
CY2024Q3	vgasw	Accrued Construction In Progress Assets Current AccruedConstructionInProgressAssetsCurrent	290265	usd
CY2023Q4	vgasw	Accrued Legal Fees AccruedLegalFees	237839	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	81500	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	143900	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36475	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7098	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2211319	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1976812	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	215104	usd
CY2024Q3	vgasw	Accrued Construction In Progress Assets Current AccruedConstructionInProgressAssetsCurrent	290265	usd
CY2023Q4	vgasw	Accrued Legal Fees AccruedLegalFees	237839	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	81500	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	143900	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7098	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2211319	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1976812	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	215104	usd
CY2024Q3	vgasw	Accrued Construction In Progress Assets Current AccruedConstructionInProgressAssetsCurrent	290265	usd
CY2023Q4	vgasw	Accrued Legal Fees AccruedLegalFees	237839	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	143900	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36475	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7098	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2211319	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1976812	usd
CY2022Q3	vgasw	Excise Tax Rate On Certain Repurchase Of Stock ExciseTaxRateOnCertainRepurchaseOfStock	0.01	pure
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2022Q3	vgasw	Percentage Of Founders Incentive Units PercentageOfFoundersIncentiveUnits	0.10	pure
CY2022Q3	vgasw	Excise Tax Rate On Certain Repurchase Of Stock ExciseTaxRateOnCertainRepurchaseOfStock	0.01	pure
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2022Q3	vgasw	Percentage Of Founders Incentive Units PercentageOfFoundersIncentiveUnits	0.10	pure
CY2022Q3	vgasw	Excise Tax Rate On Certain Repurchase Of Stock ExciseTaxRateOnCertainRepurchaseOfStock	0.01	pure
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2022Q3	vgasw	Percentage Of Founders Incentive Units PercentageOfFoundersIncentiveUnits	0.10	pure
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.05	pure
CY2023Q1	vgasw	Deferred Underwriting Fees DeferredUnderwritingFees	1700000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31858620	shares
CY2023Q1	vgasw	Business Acquisition Equity Interests Earn Out Equity Shares BusinessAcquisitionEquityInterestsEarnOutEquityShares	3500000	shares
CY2023Q1	vgasw	Business Acquisition Equity Interests Diluted Shares At Closingincluding Shares BusinessAcquisitionEquityInterestsDilutedSharesAtClosingincludingShares	35358620	shares
CY2023Q1	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	3750000	usd
CY2024Q3	us-gaap	Public Utilities Property Plant And Equipment Construction Work In Progress PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress	678243	usd
CY2023Q1	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P25Y
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	134289	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	371658	usd
CY2023Q3	vgasw	Finance Lease Cost FinanceLeaseCost	103892	usd
	vgasw	Finance Lease Cost FinanceLeaseCost	364315	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.05	pure
CY2023Q1	vgasw	Deferred Underwriting Fees DeferredUnderwritingFees	1700000	usd
CY2023Q1	vgasw	Business Acquisition Equity Interests Diluted Shares At Closingincluding Shares BusinessAcquisitionEquityInterestsDilutedSharesAtClosingincludingShares	35358620	shares
CY2023Q1	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	3750000	usd
CY2024Q3	us-gaap	Public Utilities Property Plant And Equipment Construction Work In Progress PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress	678243	usd
CY2023Q1	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P25Y
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	134289	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	145550	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	371658	usd
CY2023Q3	vgasw	Finance Lease Cost FinanceLeaseCost	103892	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	134289	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	249442	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1299000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.05	pure
CY2023Q1	vgasw	Deferred Underwriting Fees DeferredUnderwritingFees	1700000	usd
CY2023Q1	vgasw	Business Acquisition Equity Interests Earn Out Equity Shares BusinessAcquisitionEquityInterestsEarnOutEquityShares	3500000	shares
CY2023Q1	vgasw	Business Acquisition Equity Interests Diluted Shares At Closingincluding Shares BusinessAcquisitionEquityInterestsDilutedSharesAtClosingincludingShares	35358620	shares
CY2023Q1	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	3750000	usd
CY2024Q3	us-gaap	Public Utilities Property Plant And Equipment Construction Work In Progress PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress	678243	usd
CY2023Q1	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P25Y
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	134289	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	145550	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	342782	usd
CY2023Q3	vgasw	Finance Lease Cost FinanceLeaseCost	103892	usd
	vgasw	Finance Lease Cost FinanceLeaseCost	364315	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	134289	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	249442	usd
	us-gaap	Lease Cost LeaseCost	371658	usd
	us-gaap	Lease Cost LeaseCost	707097	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	353162	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	273712	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P17M
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5M6D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	803628	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	108011	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54620	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45506	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	749008	usd
CY2024Q3	vgasw	Net Of Cost Reimbursements NetOfCostReimbursements	1218228	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1236016	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1840637	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.99
CY2024Q3	us-gaap	Lease Cost LeaseCost	134289	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	249442	usd
	us-gaap	Lease Cost LeaseCost	707097	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	353162	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	273712	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P17M
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5M6D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	803628	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	108011	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54620	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45506	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	749008	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62505	usd
CY2024Q3	vgasw	Net Of Cost Reimbursements NetOfCostReimbursements	1218228	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1840637	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1236016	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
	us-gaap	Lease Cost LeaseCost	371658	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	353162	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	273712	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5M6D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	803628	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	108011	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54620	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45506	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	749008	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62505	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1840637	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.046	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1236016	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1840637	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.99
	vgasw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Lifeyears Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeyearsGranted	P7Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3076653	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2767651	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7.67
	vgasw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Lifeyears Unvested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeyearsUnvested	P6Y3M18D
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15383263	shares
	vgasw	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays	P20D
	vgasw	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays	P30D
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	335984	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0208	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0208	pure
	vgasw	Net Cash Savings Percentage NetCashSavingsPercentage	0.15	pure
	vgasw	Payment Of Cap Amount PaymentOfCapAmount	50000000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-777732	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-773192	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2453810	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21694291	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20036271	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1840637	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.99
	vgasw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Lifeyears Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeyearsGranted	P7Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3076653	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2767651	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7.67
	vgasw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Lifeyears Unvested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeyearsUnvested	P6Y3M18D
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15383263	shares
	vgasw	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays	P20D
	vgasw	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays	P30D
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	335984	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0208	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0208	pure
	vgasw	Net Cash Savings Percentage NetCashSavingsPercentage	0.15	pure
	vgasw	Payment Of Cap Amount PaymentOfCapAmount	50000000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-777732	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-773192	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2453810	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21694291	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20036271	shares
	vgasw	Development Cost Percentage DevelopmentCostPercentage	0.65	pure
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
	vgasw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Lifeyears Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeyearsGranted	P7Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3076653	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2767651	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7.67
	vgasw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Lifeyears Unvested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeyearsUnvested	P6Y3M18D
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15383263	shares
	vgasw	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays	P20D
	vgasw	Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays	P30D
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	335984	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0208	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0208	pure
	vgasw	Net Cash Savings Percentage NetCashSavingsPercentage	0.15	pure
	vgasw	Payment Of Cap Amount PaymentOfCapAmount	50000000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-777732	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-773192	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2453810	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2096801	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21694291	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20036271	shares
	vgasw	Development Cost Percentage DevelopmentCostPercentage	0.65	pure
	vgasw	Development Cost Percentage DevelopmentCostPercentage	0.65	pure
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
CY2024Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	vgasw	Stock Issued During Period Value Retroactive Application Of Recapitalization StockIssuedDuringPeriodValueRetroactiveApplicationOfRecapitalization		usd
	vgasw	Class A Sponsor Earn Out Shares ClassASponsorEarnOutShares		usd
	vgasw	Class C Sponsor Earn Out Shares ClassCSponsorEarnOutShares		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	vgasw	Reimbursement Of Capital Expenditures ReimbursementOfCapitalExpenditures		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	vgasw	Proceeds From Trust ProceedsFromTrust		usd
	vgasw	Paymentsof Transaction Expenses PaymentsofTransactionExpenses		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q3	vgasw	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired		usd
	vgasw	Noncash Income Tax Payable And Deferred Tax Liability Obtained From Cenaq NoncashIncomeTaxPayableAndDeferredTaxLiabilityObtainedFromCENAQ		usd
	vgasw	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination		usd
	vgasw	Capital Expenditures In Accounts Payable And Accrued Expensesat Period End CapitalExpendituresInAccountsPayableAndAccruedExpensesatPeriodEnd		usd
CY2023Q4	vgasw	Accrued Construction In Progress Assets Current AccruedConstructionInProgressAssetsCurrent		usd
CY2024Q3	vgasw	Finance Lease Cost FinanceLeaseCost		usd
	vgasw	Finance Lease Cost FinanceLeaseCost		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001841425
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
CY2024Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	vgasw	Stock Issued During Period Value Retroactive Application Of Recapitalization StockIssuedDuringPeriodValueRetroactiveApplicationOfRecapitalization		usd
	vgasw	Class A Sponsor Earn Out Shares ClassASponsorEarnOutShares		usd
	vgasw	Class C Sponsor Earn Out Shares ClassCSponsorEarnOutShares		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	vgasw	Reimbursement Of Capital Expenditures ReimbursementOfCapitalExpenditures		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	vgasw	Proceeds From Trust ProceedsFromTrust		usd
	vgasw	Paymentsof Transaction Expenses PaymentsofTransactionExpenses		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q3	vgasw	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired		usd
	vgasw	Noncash Impact Of Debt Issuance Through The Business Combination NoncashImpactOfDebtIssuanceThroughTheBusinessCombination		usd
	vgasw	Accounts Receivable For Reimbursement Of Capital Expenditures AccountsReceivableForReimbursementOfCapitalExpenditures		usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent		usd
CY2023Q4	vgasw	Accrued Construction In Progress Assets Current AccruedConstructionInProgressAssetsCurrent		usd
CY2024Q3	vgasw	Accrued Legal Fees AccruedLegalFees		usd
CY2024Q3	vgasw	Finance Lease Cost FinanceLeaseCost		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001841425
CY2024Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	vgasw	Stock Issued During Period Value Retroactive Application Of Recapitalization StockIssuedDuringPeriodValueRetroactiveApplicationOfRecapitalization		usd
	vgasw	Class A Sponsor Earn Out Shares ClassASponsorEarnOutShares		usd
	vgasw	Class C Sponsor Earn Out Shares ClassCSponsorEarnOutShares		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	vgasw	Reimbursement Of Capital Expenditures ReimbursementOfCapitalExpenditures		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	vgasw	Proceeds From Trust ProceedsFromTrust		usd
	vgasw	Paymentsof Transaction Expenses PaymentsofTransactionExpenses		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q3	vgasw	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired		usd
	vgasw	Noncash Income Tax Payable And Deferred Tax Liability Obtained From Cenaq NoncashIncomeTaxPayableAndDeferredTaxLiabilityObtainedFromCENAQ		usd
CY2023Q4	vgasw	Accrued Construction In Progress Assets Current AccruedConstructionInProgressAssetsCurrent		usd
CY2024Q3	vgasw	Accrued Legal Fees AccruedLegalFees		usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1		usd
CY2024Q3	vgasw	Finance Lease Cost FinanceLeaseCost		usd
	vgasw	Finance Lease Cost FinanceLeaseCost		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001841425

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-24-097136-index-headers.html	Edgar Link	pending
0001213900-24-097136-index.html	Edgar Link	pending
0001213900-24-097136.txt	Edgar Link	pending
0001213900-24-097136-xbrl.zip	Edgar Link	pending
ea0219215-10q_verdeclean.htm	Edgar Link	pending
ea021921501ex31-1_verdeclean.htm	Edgar Link	pending
ea021921501ex31-2_verdeclean.htm	Edgar Link	pending
ea021921501ex32-1_verdeclean.htm	Edgar Link	pending
ea021921501ex32-2_verdeclean.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0219215-10q_verdeclean_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vgasw-20240930.xsd	Edgar Link	pending
vgasw-20240930_def.xml	Edgar Link	unprocessable
vgasw-20240930_cal.xml	Edgar Link	unprocessable
vgasw-20240930_pre.xml	Edgar Link	unprocessable
vgasw-20240930_lab.xml	Edgar Link	unprocessable
0001213900-24-097136-index-headers.html	Edgar Link	pending
0001213900-24-097136-index.html	Edgar Link	pending
0001213900-24-097136.txt	Edgar Link	pending
0001213900-24-097136-xbrl.zip	Edgar Link	pending
ea0219215-10q_verdeclean.htm	Edgar Link	pending
ea021921501ex31-1_verdeclean.htm	Edgar Link	pending
ea021921501ex31-2_verdeclean.htm	Edgar Link	pending
ea021921501ex32-1_verdeclean.htm	Edgar Link	pending
ea021921501ex32-2_verdeclean.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
ea0219215-10q_verdeclean_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vgasw-20240930.xsd	Edgar Link	pending
vgasw-20240930_def.xml	Edgar Link	unprocessable
vgasw-20240930_pre.xml	Edgar Link	unprocessable
vgasw-20240930_lab.xml	Edgar Link	unprocessable
vgasw-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VGAS
Verde Clean Fuels Inc Stock $vgas

2024 Q3 Form 10-Q Financial Statement

#000121390024097136 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VGAS Verde Clean Fuels Inc Stock $vgas

2024 Q3 Form 10-Q Financial Statement

#000121390024097136 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VGAS
Verde Clean Fuels Inc Stock $vgas